As of Jun 2023 · from KAZU BY WELLNESS INSIGHT TECHNOLOGIES, INC. Round 2023 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$21,347
Across 1 round since 2023
Financials
FY2020–FY2023 · from SEC filings · hover any figure for its source
$558K
−$420K
2020
$340K
−$594K
2021
$185K
−$266K
2022
$177K
−$8K
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
FY2023
Income statement
Revenue
$558,466
$340,169
$185,498
$177,273
Cost of goods sold
$16,105
$10,554
$3,085
$0
Gross margin
97%
97%
98%
100%
Net income
-$420,310
-$594,126
-$266,315
-$8,334
Taxes paid
$0
$0
$20,517
$2,292
Balance sheet
Cash
$132,707
$110,958
$4,509
$2,666
Accounts receivable
$0
$35,663
$658,450
$81,407
Total assets
$220,910
$171,274
$712,580
$127,480
Short-term debt
$274,939
$214,740
$742,148
$57,957
Long-term debt
$549,741
$1,000,641
$793,852
$891,387
Total liabilities
$824,680
$1,215,381
$1,536,000
$949,344
Other
Headcount
—
4
—
3
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
KAZU BY WELLNESS INSIGHT TECHNOLOGIES, INC. Round 2023
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.